Accumulation of degradation products of doxorubicin and pirarubicin formed in cell culture medium within sensitive and resistant cells

Biochem Pharmacol. 1993 Feb 9;45(3):659-65. doi: 10.1016/0006-2952(93)90140-r.

Abstract

Quantitative study of doxorubicin (Adriamycin), pirarubicin (4'-o-tetrahypyranyladriamycin) and daunorubicin in the nucleus of living cells was performed using microspectrofluorometry. As for the cytotoxic assays, drug-sensitive and drug-resistant K562 cells were incubated for 3 days with concentrations of drug ranging from 4 nM to 1 mM. When drug-sensitive cells were incubated with pirarubicin, the spectrum recorded from inside the nucleus was characteristic of anthracycline intercalated between the base pairs in the nucleus. However, when drug-sensitive cells were incubated with doxorubicin and drug-resistant cells with pirarubicin or doxorubicin, a new fluorescent spectrum was obtained which was due to 7,8-dehydro-9,10-desacetyldoxorubicinone, a pirarubicin and doxorubicin degradation product that is formed in the medium. This compound which is highly lipophilic is taken up rapidly into both sensitive and resistant cells.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Animals
  • Buffers
  • Cell Line / metabolism
  • Cell Nucleus / metabolism
  • Culture Media / metabolism
  • DNA / metabolism
  • Daunorubicin / metabolism
  • Dose-Response Relationship, Drug
  • Doxorubicin / analogs & derivatives*
  • Doxorubicin / chemistry
  • Doxorubicin / metabolism*
  • Drug Resistance
  • Membrane Glycoproteins / metabolism
  • Spectrometry, Fluorescence
  • Time Factors

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Buffers
  • Culture Media
  • Membrane Glycoproteins
  • 7,8-dehydro-9,10-desacetyldoxorubicinone
  • Doxorubicin
  • DNA
  • pirarubicin
  • Daunorubicin